Nur Dikmen

Dr. Nur Dikmen

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2017 in Hong Kong Medical Journal
Verified
Journal Article
Open access
MYMesut E Yaman
Mesut E Yaman
AKAtilla Kazancı
Atilla Kazancı
NDNur Dikmen
Nur Dikmen
FBFerhat Baş
Ferhat Baş
GAGıyas Ayberk
Gıyas Ayberk
The most common cause of poor outcome following lumbar disc surgery is recurrent herniation. Recurrence has been noted in 5% to 15% of patients with surgically treated primary lumbar disc herniation. There have been many studies designed to determine the risk factors for recurrent lumbar disc herniation. In this study, we retrospectively analysed the influence of disc degeneration, endplate changes, surgical technique, and patient's clinical characteristics on recurrent lumbar disc herniation.

1 April 2015 in The Spine Journal
Verified
Journal Article
Closed access
MYMesut Emre Yaman
Mesut Emre Yaman
AGAhmet Gudeloglu
Ahmet Gudeloglu
SSSalim Senturk
Salim Senturk
NDNur Dikmen
Nur Dikmen
TTTolga Tolunay
Tolga Tolunay
AAArslan Kağan Arslan
Arslan Kağan Arslan

29 November 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
AHAli İhSan Hasde
Ali İhSan Hasde
MSMehmet Cahit Sarıcaoğlu
Mehmet Cahit Sarıcaoğlu
NDNur Dikmen
Nur Dikmen
ÇBÇağdaş Baran
Çağdaş Baran
EÖEvren Özçınar
Evren Özçınar
AAAhmet Ruchan Akar
Ahmet Ruchan Akar
Our goal was to compare the haemodynamic effects of different mechanical left ventricular (LV) unloading strategies and clinical outcomes in patients with refractory cardiogenic shock supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO). A total of 448 patients supported with VA-ECMO for refractory cardiogenic shock between 1 March 2015 and 31 January 2020 were included and analysed in a single-centre, retrospective case–control study. Fifty-three patients (11.8%) on VA-ECMO required LV unloading. Percutaneous balloon atrial septostomy (PBAS), intra-aortic balloon pump (IABP) and transapical LV vent (TALVV) strategies were compared with regards to the composite rate of death, procedure-related complications and neurological complications. The secondary outcomes were reduced pulmonary capillary wedge pressure, pulmonary artery pressure, central venous pressure, left atrial diameter and resolution of pulmonary oedema on a chest X-ray within 48 h. No death related to the LV unloading procedure was detected. Reduction in pulmonary capillary wedge pressure was highest with the TALVV technique (17.2 ± 2.1 mmHg; P < 0.001) and was higher in the PBAS than in the IABP group; the difference was significant (9.6 ± 2.5 and 3.9 ± 1.3, respectively; P = 0.001). Reduction in central venous pressure with TALVV was highest with the other procedures (7.4 ± 1.1 mmHg; P < 0.001). However, procedure-related complications were significantly higher with TALVV compared to the PBAS and IABP groups (50% vs 17.6% and 10%, respectively; P = 0.015). We observed no significant differences in mortality or neurological complications between the groups. Our results suggest that TALVV was the most effective method for LV unloading compared with PBAS and IABP for VA-ECMO support but was associated with complications. Efficient LV unloading may not improve survival.

1 July 2017 in International Angiology
Verified
Journal Article
Closed access
EÖEvren Özçınar
Evren Özçınar
MCMehmet Cakici
Mehmet Cakici
NDNur Dikmen
Nur Dikmen
CBCagdas Baran
Cagdas Baran
AAAnar Aliyev
Anar Aliyev
MSMustafa Sirlak
Mustafa Sirlak
Article: Thrombus resolution and right ventricular functional recovery using ultrasound-accelerated thrombolysis in acute massive and submassive pulmonary embolism - International Angiology 2017 October;36(5):428-37 - Minerva Medica - Journals

28 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NDNur Dikmen
Nur Dikmen
EÖEvren Özçınar
Evren Özçınar
ZEZeynep Eyileten
Zeynep Eyileten
AHAli Ihsan Hasde
Ali Ihsan Hasde
LYLevent Yazicioglu
Levent Yazicioglu
AUAdnan Uysalel
Adnan Uysalel
Background: Aortic coarctation, a condition characterized by localized narrowing of the aorta, can be managed with either surgical or endovascular techniques. This study aims to compare these approaches concerning long-term outcomes, particularly re-coarctation rates and late arterial hypertension. Methods: We retrospectively analyzed data from patients with native, isolated aortic coarctation treated by surgical or endovascular methods between 2015 and 2024. Clinical and demographic data were collected from electronic health records. Blood pressure was measured using oscillometric devices, and transthoracic echocardiography (TTE) was performed by an experienced sonographer. The primary endpoint was to identify which treatment predicted re-coarctation during follow-up, while the secondary endpoint assessed the incidence of late arterial hypertension. Results: Sixty-nine patients were included, with a mean age of 18.14 ± 8.18 years (median 16 years; range 8 to 37 years) and a median follow-up of 3 years (range 6 months to 8 years). Of these, 67 (97.1%) underwent elective repairs. Repair techniques included endovascular treatment (24.6%), surgical end-to-end anastomosis (47.8%), and surgical patchplasty (27.5%). The endovascular group was significantly older (29.82 ± 5.9 years vs. 14.33 ± 4.25 years, p = 0.056) and had shorter procedure durations and hospital stays. One-year freedom from reintervention was significantly higher in the surgical group (98.7%) compared to the endovascular group (88.23%) (p < 0.001). Conclusions: Both techniques effectively treat aortic coarctation, but surgical repair offers better long-term outcomes, while endovascular repair provides shorter recovery times. These findings should inform the choice of treatment modality based on patient-specific factors and clinical priorities.

26 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EÖEvren Özçınar
Evren Özçınar
NDNur Dikmen
Nur Dikmen
Cagdas BaranCagdas Baran
Cagdas Baran
OBOnur Buyukcakir
Onur Buyukcakir
MKMelisa Kandemir
Melisa Kandemir
LYLevent Yazicioglu
Levent Yazicioglu
Background: Thoracic endovascular aortic repair (TEVAR) has become the first-line therapy for descending aortic disease. Recent studies have demonstrated that preventive revascularization of the left subclavian artery (LSA) in zone 2 TEVAR cases reduces the risk of neurological complications. However, there is no uniform consensus on the choice of revascularization techniques. Although carotid-subclavian bypass is considered the gold standard method, in situ fenestration techniques have also shown encouraging results. This study aims to compare the carotid-LSA bypass with in situ fenestration (ISF) for LSA revascularization and to discuss our treatment approach. Methods: We conducted a retrospective review of all patients undergoing zone 2 TEVAR with in situ fenestration (ISF) or carotid-subclavian artery bypasses for LSA revascularization at our institution between February 2011 and February 2024. Preoperative patient characteristics and primary outcomes, such as operative mortality, transient ischemic attack, stroke, and spinal cord ischemia, were analyzed between the groups. Results: During the 13-year study period, 185 patients underwent TEVAR procedures. Of these, 51 patients had LSA revascularization with zone 2 TEVAR; 32 patients underwent carotid-subclavian artery bypasses, and 19 underwent in situ fenestration. The technical success rate was 100%. Statistically, there was no significant difference between the groups in terms of primary outcomes such as stroke, transient ischemic attack, spinal cord ischemia, and death (p > 0.05). Conclusions: In situ fenestration (ISF) may be an effective and feasible method for LSA revascularization. With precise patient selection and in experienced hands, ISF appears to be associated with similar perioperative outcomes and mortality rates to the carotid-subclavian bypass.